Cardiovascular safety of dihydroergotamine mesylate delivered by precision olfactory delivery (INP104) for the acute treatment of migraine Article (Web of Science) Early Access (Web of Science)

cited authors

  • Dafer, Rima M.; Tietjen, Gretchen E.; Rothrock, John F.; Vann, Robert E.; Shrewsbury, Stephen B.; Aurora, Sheena K.

publication date

  • May 27, 2024

webpage

published in

category

keywords

  • INP104
  • cardiovascular
  • dihydroergotamine mesylate
  • migraine
  • precision olfactory delivery